Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice

Abstract: Severe aplastic anemia (SAA) is a rare and life-threatening bone marrow failure disorder. Immunosuppressive therapy (IST) with antithymocyte globulin and cyclosporine has long been a frontline treatment option in SAA; however, its limited durability and risk of long-term complications such...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Neel S. Bhatt, Azra Borogovac, Yvonne A. Efebera, Anna DeSalvo, Steven M. Devine, Amy Foley, Valerie Greco-Stewart, Betty K. Hamilton, Mykala Heuer, Todd Molfenter, John P. Plastaras, Brittany K. Ragon, Sarah A. Wall, Larisa Broglie, Mark B. Juckett, Nandita Khera, Mary M. Horowitz, Amy E. DeZern
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2025-09-01
Saila:	Blood Advances
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2473952925003568
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!